Question 1

What are some methods or practices to rationally and effectively discuss issues and resolve conflict?(What would your plan be to determine if the undesired patient outcomes are related to policy, related toprocedure, or related to some other issue?

Question 2

What are the differences between the Personnel Policy Manual and the Employee Guide?

Question 3

How do you plan to create procedures from policies?

Question 4

What kind of tools would you use to create procedures?

Question 5

How do you determine if each manager is up to date with the policies and procedures?

Question 6

How often should policies and procedures be updated?

Question 7

Who performs the updates to policies and procedures?

In your own words, ( not an answer from the same question on chegg) Select one issue from the Transitional Care scenario in the Allied Health Community and write a new policy and procedure related to the issue. Write a 500-word memo to your supervisor that describes this issue and an explanation of how the new policy and procedure will resolve the issue. In the memo, include a draft of the policy and procedure. Be sure to include the research on industry standards that helped you formulate the policy and procedure.

Scenario: As the Director of Human Resources at a transitional health care organization, you are charged with the overall administration of over 700 health care professional employees. This transitional health care organization is currently celebrating its 40th year in the community and serves as a model organization envied by local competitors. As the Director of Human Resources, you are responsible for hiring, orientation, training and development, compensation and benefits, and employee relations. Given the long existence of the organization, there have been many instances where management has been tasked with creating or modifying the company personnel policies and procedures. You have recently met with the CEO regarding some topics related to human resources, including the concern that the facility is experiencing some complaints regarding management, especially in the area of employee-related adverse actions. Some employees complain that they are being unfairly singled out for corrective actions and progressive discipline. They claim that current policies are being unfairly administered and some of the policies are out of date. Additionally, there have been too many medication errors and harmful patient treatments by the nursing staff that have resulted in nursing management creating new policies and procedures in an effort to fix immediate issues. The CEO has directed you to resolve these issues. Given the above scenario, respond to each question with and include references to support your proposed solution.

This is the question about the java problem, please give the detail comment and code of each class.

Please write tests for all the code of all the classes

Thank you

Create a class Mammal with the following UML diagrams:
+---------------------------------+
| Mammal |
+---------------------------------+
| - name: String |
+---------------------------------+
| + Mammal(String name) |
| + getName(): String |
| + isCookable(): boolean |
| + testMammal(): void | (this method is static )
+---------------------------------+
The isCookable method of the Mammal class returns a boolean indicating whether the mammal can be cooked or not: some mammals can be cooked and some mammals cannot be cooked so for safety reasons the isCookable method just prints a message "Do not cook this!" and returns false (because the isCookablemethod must return a boolean).
Add a class Human to your program. A human is a mammal. The constructor for the Human class takes no argument. All humans are named "Alice" and humans cannot be cooked (the isCookable method must not print any message though, it simply returns false).
Add a class Rabbit to your program. A rabbit is a mammal. The Rabbit class has a private instance variable weight of type double that describes the weight of the rabbit, and a getWeight method. The constructor for the Rabbit class takes the rabbit’s name and the rabbit’s weight as arguments. A rabbit can be cooked.
Add a class EuropeanRabbit to your program. European rabbit is a species of rabbit. The EuropeanRabbitclass has two constructors: the first constructor takes the European rabbit’s name and the European rabbit’s weight as arguments; the second constructor only takes the European rabbit’s name as argument and always uses 2.0 as the European rabbit’s weight. The second constructor must use the first constructor.
Add a class LapinSautéChasseur to your program. Lapin sauté chasseur is a kind of European rabbit. The constructor for the LapinSautéChasseur class takes no argument. Lapin sauté chasseur is always named "Delicious" and has a weight of 0.5.
Add a class FrankTheRabbit to your program. Frank The Rabbit is a kind of rabbit. The constructor for theFrankTheRabbit class takes no argument. Frank The Rabbit is always named "Frank", has a weight of 100.0, and cannot be cooked.
Add a class Start to your program to test all your classes.
Question 2
Add a class CastIronPot to your program with the following UML diagram:
+---------------------------------+
| CastIronPot |
+---------------------------------+
| - rabbit: Rabbit |
+---------------------------------+
| + CastIronPot(Rabbit rabbit) |
| + getRabbit(): Rabbit |
| + testCastIronPot(): void |(this method is static)
+---------------------------------+
In the testCastIronPot method, create a lapin sauté chasseur called lsc1, then create a cast iron pot with this lapin sauté chasseur in it. Then get the lapin sauté chasseur from the cast iron pot and store it into a local variable called lsc2 of type LapinSautéChasseur. Use the == operator to check that lsc1 and lsc2 are the same lapin sauté chasseur.

1. In fatty acid oxidation, ATP is consumed in which step?

a. Transport of acyl CoA into the mitochondria

b. Formation of the acyl-CoA

c. Thiolysis of the ketoacyl- CoA intermediate

d. Conversion of acyl-CoA into enoyl-CoA

e. Formation of malonyl-CoA

2. If b-oxidation and citric acid cycle reactions completed the oxidation 3 molecules of hexanoic acid (6 carbon carboxylic acid) to CO₂, how many CO₂, NADH and FADH₂ would be produced? (SHOW WORK)

CO₂               _______

NADH           _______

FADH₂         _______

3. Match each process with the location within the body/cell where it occurs: Chose all that apply.

   b-oxidation of fatty acids ________                                   a. Intestinal lumen

   emulsification of TAG _______ b. intestinal brush border cells

   fatty acid synthesis ________ c. mitochondrial matrix

   formation of chylomicrons ________                                 d. cytosol

   formation of micelles _________ e. peroxisomes

   formation of fatty acyl-CoA ________

4. A defective Translocase component of the Fatty acid transport system, or a deficiency of carnitine would likely result in:

a. Higher than normal levels of Fatty Acyl CoA in the mitochondrial matrix

b. Higher than normal levels of Fatty Acyl CoA in the cytosol

c. Higher than normal levels of acetyl CoA in the cytosol

d. Higher than normal levels of acetyl CoA in the mitochondrial matrix

e. Higher than normal levels of acyl Carnitine in the mitochondrial matrix

1) How is the atomic mass if an element calculated?

a) Protons plus electron

b) Electron plus neutrons

c) Protons plus neutrons

d) Number of protons

2) Carbonic acid is a useful buffer in the blood. What is its purpose?

a) Regulate water content

b) Regulate blood flow

c) Regulate pH

d) Regulate metabolism

3) The substance in which the solute is dissolving into is known as the

a) Suspension

b) Mixture

c) Solution

d) Solvent

4) Bacon grease is solid at room temperature and vegetable oil is a liquid. Although they have different properties, what type of biochemical compound describes both of them?

a) Nucleic acids

b) Carbohydrates

c) Lipids

d) Proteins

5) An isotope has the same number of protons and a

a) Different number of electrons

b) Different number of neutrons

c) Different number of electrons and neutrons

d) Same number of electrons as neutrons

6) What is the molecular weight of ethanol; C2H5OH (atomic weight of each elements are C=12g/mol, H=1 g/mol, O=10g/mol)?

a) 46 g/mol

b) 45 /mol

c) 34 g/mol

d) 40 g/mol

7) What chemical compound is a base?

a) NaOH

b) NaCL

c) KCL

d) HCL

Question 10

A solution of a compound in water conducts electricity, turns litmus red, and has a sour taste. What compound might be in the solution?

Select the correct answer below:

NaHCO3

Mg(OH)2

C3H5(COOH)3

NH3

Content attribution- Opens a dialog

Question 11

When ranking the strength of acids in aqueous solution, water is acting as:

a base.

an acid.

both an acid and a base.

neither an acid nor a base.

Content attribution- Opens a dialog

Question 12

Use the periodic table below to answer the question that follows.

Which is a possible example of species that can comprise a buffer solution?

Select the correct answer below:

HClO4 and ClO−4

H2SO4 and H2O

H2PO−4 and H3PO4

CH3OH and CH3COOH

Content attribution- Opens a dialog

Question 13

Which of the following is the term for the reaction between two molecules of the same neutral substance to produce an ion pair?

Select the correct answer below:

autoionization

stepwise ionization

bimolecular reaction

recursive reaction

Content attribution- Opens a dialog

Question 14

An aqueous solution at 25∘C has a hydronium ion concentration of 9.7×10−5 M. What is the hydroxide ion concentration of the solution?

Select the correct answer below:

9.7×10−19 M

9.7×10−12 M

1.0×10−10 M

1.0×10−3 M

Content attribution- Opens a dialog

The purpose of the lysis procedure is:

to sequence the 16S rRNA gene

to separate the pieces of nucleic acid from one another

to break open the bacterial cells to release the genetic material

to amplify the 16S rRNA gene

Match the components of HotShot buffer with their role.

NaOH    

            removes anions so they cannot be used as cofactors by enzymes, increases pH to denature nucleases, disrupts lipid membranes, removes cations so they cannot be used as cofactors by enzymes, or decreases pH to denature nucleases

Detergent

            removes anions so they cannot be used as cofactors by enzymes, increases pH to denature nucleases, disrupts lipid membranes, removes cations so they cannot be used as cofactors by enzymes, or decreases pH to denature nucleases

Chelator

             (removes cations so they cannot be used as cofactors by enzymes)

When taking some of your bacterial isolate to place in the HotShot buffer you should take as much as can fit on the end of the pipette tip.

True OR False

The role of neutralization buffer is to:

restore the pH to approximately neutral

increase the pH to 10

introduce nucleases into the reaction

decrease the pH to 3

Nuclease-free water is added to the reaction mix to _____________________. Choose all that apply.

increase the volume of the solution without introducing nucleases which could degrade the nucleic acids

dilute the lysate so it is not too concentrated for later procedures

to stop the chemical reactions occuring in the solution

add nucleases to the reaction mix

Hi! Can someone summarize what the reaction article is saying? I am having trouble understanding it.

The purpose of this experiment was to investigate the catalytic performance of solid acid catalyst developed from modification of coal combustion fly ash to synthesize methyl 4-aminobenzoate (MAB) by Fischer esterification between 4-aminobenzoic acid and methanol. Upon acid modification of fly ash, surface acidity of solid acid catalyst (SAC) is greatly enhanced as a result of increased surface area, augmented silica content, and fabricated phosphates. The proposed mechanism, similar to our lab, demonstrates that the surface acid sites of solid acid catalyst (SAC) initiate the reaction by donating proton to 4-aminobenzoic acid, resulting in the formation of carbocation, which is then attacked by the electron-rich oxygen atom of methanol. Subsequent loss of water and deprotonation resulted in the formation of the desired product, MAB. Recyclability study reveals that the solid acid catalyst (SAC) retains similar catalytic activity till the fifth reaction cycle furnishing the yield of methyl 4-aminobenzoate in the range 82–98% This unveils that the acidity remains unaffected during regeneration of the catalyst. This eco-friendly, highly efficient, and low-cost solid acid catalyst system may be used as a replacement of harmful traditional liquid acids for important reactions in pharmaceutical industries to synthesize indispensable drugs.

. Currently, most of Homer’s body cells are using glucose to make ATP.    His adipose cells are taking in fatty acids and storing them as triglycerides. He probably had a doughnut ______, and his liver cells are probably _______ glycogen.

  Recently; synthesizing

   Many hours ago; synthesizing

   Many hours ago; breaking down

   Recently; breaking down

2. Which of the following is FALSE regarding calcium:

a. calcium is required for proper blood clotting

b. the parathyroid glands monitor blood calcium

c. calcitonin causes calcium to be deposited in bone in adults but not children

d. calcitriol is required for proper absorption of dietary calcium

e .calcium is part of some second-messenger systems

3 Connie visits her doctor after she stumbles on her stairway and incurs a bone fracture. Her physician conducts a bone density test and determines that her bones are very thin for her age. He then takes a blood sample and finds that she has extremely elevated levels of Ca2+ in her blood. Which structure in her body is he most likely to suspect a problem with?

a The thyroid gland

b. The kidneys

c. The parathyroid glands

d The adenohypophys

4. Which of the following is NOT a peptide hormone?

  Glucagon

   Insulin

   Erythropoietin

   Progesterone

5 Which of the following would diffuse across the membrane of its target cell?

  Epinephrine

   Oxytocin

   Thyroid Stimulating Hormone

   Melanocyte Stimulating Hormone

   Tri-iodothyronine

PH experiment:

What is one real-world or practical application for this experiment or portion of this experiment?

Define the following: abscissa, acid, base, endpoint, equivalence point, neutralization, pH, pKa, mono- protic acid, polyprotic acid, ordinate, strong acid, strong base, and weak acid.

Draw the structure of each of the acids in Table 1.

Produce data tables for each of your runs. Leave room in your notebook for lots of data. Record the actual volume of titrant and solution pH as you conduct the experiment.

Identify all potentially hazardous steps in your procedure. In your own words, explain what safety precautions should be taken and why.

Consider the titration of 0.050 M HCl with 0.050 M NaOH. Calculate the pH: (a) of the pure HCl solution; (b) of 25.00 mL acid plus 12.50 mL base; (c) at the equivalence point; and (d) of 25.00 mL acid and 37.50 mL base.

Consider the titration of 0.050 M NaOH with 0.050 M HCl. Calculate the pH: (a) of the pure NaOH solution; (b) of 25.00 mL base plus 12.50 mL acid; (c) at the equivalence point; and (d) of 25.00 mL base and 37.50 mL acid.

In one experiment, an unknown acid was titrated with NaOH. The pH at the equivalence point was 7.75. Was the unknown acid strong or weak? Explain. Hint: The pH of pure water at room temperature is 7.

Cooperative Research Ethics Review Boards: A Win-Win Solution?

Enhancing public participation in research is one of the central challenges facing the clinical research enterprise in the United States, and one of its highest priorities.^[1] Public concern about the safety of participating in research is increasing, reflected in a rising tide of litigation, negative articles in the popular press, and other published commentaries.^[2] Part of this concern focuses on Research Ethics Review Boards (Research ERBs)the entities responsible for ethical review and oversight of human research. These bodies, referred to in federal regulations as Institutional Review Boards (IRBs), are overburdened and often characterized as inefficient and ineffective.^[3] The increasing number of multi-center studies is exacerbating current problems, as they often require duplicative reviews.^[4] Multiple submissions of a single protocol and its associated consent documents to several Research ERBs for review and alterations create redundancy without necessarily enhancing the protection of research subjects.^[5]

Many parties, including the Institute of Medicine (IOM), the National Bioethics Advisory Commission (NBAC), and the Department of Health and Human Services (DHHS), note that these duplicative reviews can actually detract from subject protections by diverting time and resources from more effective uses; they have suggested streamlining review through the use of alternative models.^[6] Collaborative approaches to ethical review that capture the best of both central and local processes could be more efficient, less costly and less demanding of limited resources, and also be more effective. They may allow for more timely data collection and analysis of adverse events, address the problem of institutional conflict of interest, and offer more options for unaffiliated investigators and patients with rare diseases.^[7]

Central review boards have taken on increasing importance in recent years. Reference to a "central IRB" does not necessarily mean that one Research ERB is always the IRB of record; use of the term "cooperative review" may more accurately reflect the emerging approaches discussed in this article. In a survey by the Association of American Medical Colleges (AAMC) of research deans at institutions using a Central IRB (defined as any noninstitutional board or cooperative arrangement), 53% agreed that its use shortened time to approval of research protocols. Eighty-four percent were pleased with the Central IRB review, and 77% indicated that they were able to maintain excellent local oversight of studies approved by a Central IRB.^[8] Notably, some highly respected academic institutions have turned to well-established commercial review boards after deficiencies in their local boards and processes resulted in significant enforcement actions by federal regulatory agencies. One of these private boards was among the first human research protection programs (HRPP) to receive full accreditation by the Association for Accreditation of Human Research Protection Programs (AAHRPP); the Partnership for Human Research Protection (PHRP) also has accredited independent review boards.

Many institutions are hesitant to use cooperative review mechanisms for a variety of reasons. According to the AAMC survey, those who have not used Central IRBs (76% of respondents) did not do so because of concerns about liability (73%), additional costs (60%), the absence of local representation (86%), and the inability to assess the quality of the services (56%). Federal regulations require that research review boards have "sensitivity to such issues as community attitudes,"^[9]and many institutions feel that local review is an essential component of ethical research; to what extent this view also reflects a desire to maintain institutional autonomy is unknown. Both the Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) have responded to the increasing number of multi-center trials by clarifying that existing regulations permit institutions to use joint review, rely on another qualified IRB, or make similar arrangements to avoid duplication of effort for cooperative research.^[10] OHRP and FDA also have issued further guidance that clarifies the implementation of such arrangements to ensure that the local context is taken into account.^[11]

Already, some academic organizations and the National Cancer Institute (NCI) are utilizing cooperative models to streamline the Research ERB review process. To explore the potential of these emerging ethical review mechanisms, the Clinical Research Roundtable of the IOM recently convened stakeholders in the clinical research enterprise to hear from those involved in these efforts.^[12] In this paper, we describe several models of cooperative review, many of which were presented at the meeting. These models include the Multicenter Academic Clinical Research Organization (MACRO), the Biomedical Research Alliance of New York (BRANY), independent Research ERBs, the NCI's Central IRB, and Regional Ethics Organizations (REOs). Many of these models are in the formative stages, and REOs, which are now utilized in the United Kingdom, do not exist in the U.S. at this time.^[13] Therefore, key evaluative data regarding existing central review mechanisms are not presently available; indeed, more data are needed to assess both traditional and cooperative review mechanisms and to more fully and scientifically compare these options. Our assessment is based upon the best available data about these efforts. Key issues about centralized review relate to perceived legal liability by cooperating academic institutions regarding the ability to fully reflect and address local concerns.